BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/28/2026 7:48:44 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-06-10 10:41 |
|
Peer-Review Started |
|
2025-06-10 10:42 |
|
First Decision by Editorial Office Director |
|
2025-08-06 10:59 |
|
Return for Revision |
|
2025-08-06 10:59 |
|
Revised |
|
2025-08-19 13:14 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-14 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-14 13:20 |
|
Articles in Press |
|
2025-11-14 13:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-09 00:55 |
|
Publish the Manuscript Online |
|
2026-02-28 07:48 |
| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Opinion Review |
| Article Title |
Continuous renal replacement therapy in acute liver failure
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Caleb Fisher and Stephen Warrillow |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Stephen Warrillow, Associate Professor, FRACP, PhD, Department of Intensive Care, Austin Health, 145 Studley Road, Heidelberg 3084, Victoria, Australia. stephen.warrillow@austin.org.au |
| Key Words |
Acute liver failure; Continuous renal replacement therapy; Hyperammonaemia; Cerebral oedema; Acute liver injury |
| Core Tip |
The early initiation of continuous renal replacement therapy in patients admitted to the intensive care unit with acute liver failure is safe and provides a range of benefits that are likely neuroprotective. These include control of hyperammonaemia, prevention of fever, control of acidaemia, control of fluid balance and control of electrolyte derangement. Continuous renal replacement therapy can be started in all acute liver failure patients intubated for hepatic encephalopathy and should not be delayed until evidence of renal failure becomes apparent. |
| Publish Date |
2026-02-28 07:48 |
| Citation |
Fisher C, Warrillow S. Continuous renal replacement therapy in acute liver failure. World J Crit Care Med 2026; 15(1): 110552 |
| URL |
https://www.wjgnet.com/2220-3141/full/v15/i1/110552.htm |
| DOI |
https://dx.doi.org/10.5492/wjccm.v15.i1.110552 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
